Characterising the small intestine absorptive membrane is essential to enable prediction of the systemic exposure of oral formulations. In particular, the ontogeny of key intestinal Drug Metabolising Enzymes and Transporter…
Delivers advanced data analysis and visualization capabilities to support nonclinical scientists PRINCETON, N.J.— 2023年8月28日 – Certara, Inc., a global leader in biosimulation, today announced the release of version…
On 2022年8月16日, President Biden signed the Inflation Reduction Act of 2022 (IRA) into law. One key objective of the IRA is to shift healthcare costs from patients and…
Simcyp Biopharmaceuticsソフトウェアは、バイオフォーマ、製剤、CMC分野の専門家向けの高度なPBPKプラットフォームです。
Physiologically based pharmacokinetic (PBPK) models are useful in bridging drug exposure in different ethnic groups, and there is increasing regulatory application of this approach in adults. Reported pediatric PBPK models…
As part of a collaboration between Medicines for Malaria Venture (MMV), Certara UK and Monash University, physiologically-based pharmacokinetic (PBPK) models were developed for 20 antimalarials, using data obtained from standardized…
As a pharmacologist, I’ve always been curious about how drugs work. A favorite time-killer while waiting at a doctor’s office is reading drug labels (also known as package inserts) contained…
The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and pharmaceutical industries, shifting responsibility for drug costs away from beneficiaries and onto plans and manufacturers….
医薬品の有害事象は、患者へのリスクとなるだけでなく、開発や治療目的の実現を阻害する要因にもなり得ます。Such effects can arise from primary pharmacology…
In a captivating webinar led by industry experts, Dr. Swati Jaiswal, Senior PBPK Consultant at Certara, and Dr. Erica Winter, Director of Clinical Pharmacology at EQRx, Model-Informed Formulation Development (MIFD)…
© 2025 Certara. All Rights Reserved. | 個人情報保護
